Your browser doesn't support javascript.
loading
Induction of trained immunity by influenza vaccination - impact on COVID-19.
Debisarun, Priya A; Gössling, Katharina L; Bulut, Ozlem; Kilic, Gizem; Zoodsma, Martijn; Liu, Zhaoli; Oldenburg, Marina; Rüchel, Nadine; Zhang, Bowen; Xu, Cheng-Jian; Struycken, Patrick; Koeken, Valerie A C M; Domínguez-Andrés, Jorge; Moorlag, Simone J C F M; Taks, Esther; Ostermann, Philipp N; Müller, Lisa; Schaal, Heiner; Adams, Ortwin; Borkhardt, Arndt; Ten Oever, Jaap; van Crevel, Reinout; Li, Yang; Netea, Mihai G.
Afiliación
  • Debisarun PA; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Gössling KL; Department for Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, Dusseldorf, Germany.
  • Bulut O; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Kilic G; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Zoodsma M; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Liu Z; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Oldenburg M; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Rüchel N; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Zhang B; Department for Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, Dusseldorf, Germany.
  • Xu CJ; Department for Pediatric Oncology, Hematology and Clinical Immunology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, Dusseldorf, Germany.
  • Struycken P; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Koeken VACM; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Domínguez-Andrés J; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Moorlag SJCFM; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Taks E; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Ostermann PN; Department of Occupational Health & Safety, and Environmental Service, Radboud University Medical Center, Nijmegen, Netherlands.
  • Müller L; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Schaal H; Department of Computational Biology for Individualised Infection Medicine, Centre for Individualised Infection Medicine (CiiM), a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Adams O; TWINCORE, a joint venture between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
  • Borkhardt A; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Ten Oever J; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • van Crevel R; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Li Y; Institute of Virology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, Dusseldorf, Germany.
  • Netea MG; Institute of Virology, University Hospital Duesseldorf, Medical Faculty, Heinrich Heine University Duesseldorf, Dusseldorf, Germany.
PLoS Pathog ; 17(10): e1009928, 2021 10.
Article en En | MEDLINE | ID: mdl-34695164
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la Influenza / Protección Cruzada / COVID-19 / Inmunidad Innata Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la Influenza / Protección Cruzada / COVID-19 / Inmunidad Innata Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Europa Idioma: En Revista: PLoS Pathog Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos